|
Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer Uncovered
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to Associate Professor of Oncology Barry Hudson, PhD, and additional researchers at Georgetown Lombardi working in collaboration with scientists at the University of Miami, Florida. Read more about this research.
| |
Keep Up the Momentum As We Count Down to BellRinger | |
The kickoff on Thursday, July 13 marking 100 days until the start of BellRinger weekend really got our wheels spinning. A heartfelt “thank you” to the 83 riders who answered the call to sign up! There’s still plenty of time to join the BellRinger community uniting to end cancer. Take part in the momentum that’s underway. Register now! | |
|
|
Georgetown Lombardi Faculty Meeting
Monday, July 24
12:00 - 1:00 p.m.
This meeting will be held in person (preferred) in Warwick Evans Conference Room, Building D, with the option to join via Zoom.
| |
Funding and Award Opportunities | |
 |  |
Damon Runyon Fellowship Award
The Damon Runyon Fellowship Award supports the training of the best emerging talent as they embark upon their research careers. This funding enables them to be mentored by established investigators in leading research laboratories across the country. Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO. Candidates must apply for the fellowship under the guidance of a Sponsor — a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow. Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor. Candidates who have already accepted a postdoctoral research fellowship award are not eligible. View additional eligibility criteria. This four-year award provides $70,000, $72,000, $74,000 and $76,000 in stipend support for years one, two, three, and four, respectively. In addition, an annual $2,000 expense allowance is awarded to the laboratory in which the Fellow is working and can be used by the Fellow for their educational and scientific expenses. The Foundation also provides a Dependent Child Allowance of $1,000 per child per year. View application guidelines. Application deadline: 4:00 p.m. ET, August 15, submitted through ProposalCentral.
| |
|
2023 LCCC Developmental Funds Request for Applications
Two grant opportunities designed to provide developmental funds are available for the initiation of promising new cancer-related projects leading to peer-reviewed funding and/or high-impact publications. Developmental funds support basic, translational, clinical, and population science research, as well as the center’s Community Outreach and Engagement (COE) and Cancer Research Training and Education Coordination (CRTEC) activities, by providing opportunities to investigate innovative research with an emphasis on strategic priorities for multi-PI collaboration across the Lombardi Comprehensive Cancer Center consortium. Proposals are due by September 1 and projects must begin no later than January 15, 2024. Read the request for applications and apply here.
| |
|
Federal Pancreatic Cancer Funding Opportunities
The Pancreatic Cancer Research Program (PCARP), part of the Congressionally Directed Medical Research Programs, has released its fiscal year 2023 funding opportunities. The mission of the PCARP is to promote rigorous, innovative, high-impact research that leads to earlier pancreatic cancer diagnosis, new therapeutic tools, and improved outcomes. Pre-application (letter of intent) is required. Direct questions to help@eBRAP.org or 301-682-5507. View the funding opportunities and application instructions for:
-
Focused Pilot Award: Pre-application due Sept. 14, 5:00 p.m. ET
| |
Gabrielle’s Angel Foundation 2023 Medical Research Awards
Gabrielle’s Angel Foundation funds promising physician scientists who are applying novel and state-of-the-art techniques to address fundamental problems in the genesis and treatment of blood related cancers. Applications for this year’s grants are welcome from two junior faculty members at Georgetown Lombardi – one who is conducting mainstream or conventional research and one who is conducting complementary or integrative research. Projects will be funded for a three-year period at $75,000 per year. View grant guidelines for submission (view application as a Word doc). Electronic grant submission must be received by Friday, Sept. 15, at grants@gabriellesangels.org; three hard copies of the application must be mailed to Gabrielle’s Angel Foundation and postmarked by that date as well.
| |
|
Federal Kidney Cancer Funding Opportunities
The Kidney Cancer Research Program (KCRP), part of the Congressionally Directed Medical Research Programs, has released its fiscal year 2023 funding opportunities. The KCRP focuses on issues regarding prevention, detection, treatment, including the long-term effects of kidney cancer treatment, and building capacity with next-generation investigators and resources for novel kidney cancer treatments. Pre-application (letter of intent) is required. Direct questions to help@eBRAP.org or 301-682-5507. View the funding opportunities and application instructions for:
-
Academy of Kidney Cancer Investigators Early-Career Scholar Award: Pre-application due Sept. 15, 5:00 p.m. ET
-
Clinical Trial Award: Pre-application due Sept. 15, 5:00 p.m. ET
-
Idea Development Award (New for FY23: Partnering Principal Investigator Option): Pre-application due Sept. 15, 5:00 p.m. ET
-
Translational Research Partnership Award: Pre-application due Sept. 15, 5:00 p.m. ET
-
Nurse-Initiated Research Award: Pre-application due Sept. 15, 5:00 p.m.
| |
Meetings in italics should be attended by all fellows.
| |
|
8:00 AM | Division Weekly Update Meeting | Podium A / Microsoft Teams
8:30 AM | Monday Morning Oncology Report | Inpatient Oncology Fellow | Podium A / Microsoft Teams
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528 212 194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796 253 566)
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869 742 463)
| |
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)
4:00 PM | Liver Tumor Board | Microsoft Teams
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 937 7707 3374; CME code: 80044)
| |
|
8:00 AM | Thoracic Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 993 7680 5192; Passcode: 4231; CME 86693)
12:00 PM | Melanoma Tumor Board | Podium A / Microsoft Teams (CME: 80988)
5:00 PM | GI Tumor Board | Podium A / Microsoft Teams
| |
|
9:00 AM | Cancer Research Data Meeting | No Meeting | W302 New Research Building or Zoom
9:30 AM | Head and Neck Tumor Board | Microsoft Teams
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
5:00 PM | Lymphoma Tumor Board - every other week | Microsoft Teams
5:00 PM | Myeloma Tumor Board - every other week | Microsoft Teams
| |
|
7:00 AM | CNS Tumor Board | Microsoft Teams (Meeting ID: 298 285 483 265, Passcode: rJWpmU)
12:00 PM | Oncology Grand Rounds Lecture Series | Resumes Sept. 22 | Zoom
12:00 PM | Weekly Conference (In-Person): 2023 MGUH Med/Path/Hematology Conference (Text In Code: 81202 / Text In Telephone: 202-796-7323); 2023 MGUH Med/Path/Onc Conference (Text In Code: 81203 / Text In Telephone: 202-796-7323) | Marietta Aud. or Podium A / Conference Link Teams
1:00 PM | Pancreas Tumor Board | Microsoft Teams
| |
Connect with Georgetown Lombardi on Social Media | |
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. | | | | |
